[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].

Klimek L, Bärhold F, Förster-Ruhrmann U, Klimek F, Rott C, Beule AG, Chaker A, Hagemann J, Huppertz T, Hoffmann TK, Dazert S, Deitmer T, Olze H, Strieth S, Wrede H, Schlenter W, Welkoborsky HJ, Wollenberg B, Albrecht T, Rudack C, Wagenmann M, Bergmann C, Cuevas M, Haxel B, Betz CS, Hoffmann AS, Beutner C, Guntinas-Lichius O, Laudien M, Gröger M, Becker S

Open source

DOI
10.1055/a-2797-4119
Published
2026 Apr
Container
Laryngo- rhino- otologie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2797-4119,
  title = {[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].},
  author = {Klimek L and Bärhold F and Förster-Ruhrmann U and Klimek F and Rott C and Beule AG and Chaker A and Hagemann J and Huppertz T and Hoffmann TK and Dazert S and Deitmer T and Olze H and Strieth S and Wrede H and Schlenter W and Welkoborsky HJ and Wollenberg B and Albrecht T and Rudack C and Wagenmann M and Bergmann C and Cuevas M and Haxel B and Betz CS and Hoffmann AS and Beutner C and Guntinas-Lichius O and Laudien M and Gröger M and Becker S},
  year = {2026},
  journal = {Laryngo- rhino- otologie},
  doi = {10.1055/a-2797-4119},
  url = {https://doi.org/10.1055/a-2797-4119}
}

RIS

TY  - JOUR
TI  - [Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].
AU  - Klimek L
AU  - Bärhold F
AU  - Förster-Ruhrmann U
AU  - Klimek F
AU  - Rott C
AU  - Beule AG
AU  - Chaker A
AU  - Hagemann J
AU  - Huppertz T
AU  - Hoffmann TK
AU  - Dazert S
AU  - Deitmer T
AU  - Olze H
AU  - Strieth S
AU  - Wrede H
AU  - Schlenter W
AU  - Welkoborsky HJ
AU  - Wollenberg B
AU  - Albrecht T
AU  - Rudack C
AU  - Wagenmann M
AU  - Bergmann C
AU  - Cuevas M
AU  - Haxel B
AU  - Betz CS
AU  - Hoffmann AS
AU  - Beutner C
AU  - Guntinas-Lichius O
AU  - Laudien M
AU  - Gröger M
AU  - Becker S
PY  - 2026
JO  - Laryngo- rhino- otologie
DO  - 10.1055/a-2797-4119
UR  - https://doi.org/10.1055/a-2797-4119
ER  - 

APA

L, K., F, B., U, F., F, K., C, R., AG, B., A, C., J, H., T, H., TK, H., S, D., T, D., H, O., S, S., H, W., W, S., HJ, W., B, W., T, A., C, R., M, W., C, B., M, C., B, H., CS, B., AS, H., C, B., O, G., M, L., M, G., & S, B. (2026). [Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].. Laryngo- rhino- otologie. https://doi.org/10.1055/a-2797-4119

Source records